Avacta Group Debt 2024

Avacta Group Aktienanalyse

What does Avacta Group do?

Avacta Group PLC is a British company specializing in the development of innovative solutions for biotechnology and diagnostics. It was founded in 2004 by Eliot Forster and is headquartered in Wetherby, West Yorkshire. Avacta's history began with the development of Affimer technology, which offers an alternative to conventional antibodies. Affimers are synthetic peptides with high binding affinity to biological molecules, making them important tools for biomedical research and diagnostic applications. The company had limited resources in its early years, and it took several years to complete the development of Affimer technology. In recent years, Avacta has expanded its business model by offering licensed services to pharmaceutical companies. The company provides innovative screening methods and drug discovery tools based on Affimer technology. Avacta has partnerships with major companies such as LG Chem, Moderna, and Wockhardt. The partnership with LG Chem aims to use the platform technology for the development of Covid-19 therapeutics, while the collaboration with Wockhardt focuses on the creation of diagnostic kits and test systems. Avacta's main business areas are biotechnology and diagnostics. The biotechnology division offers screening services for pharmaceutical companies, with a focus on developing higher quality and more efficient antibodies using Affimers, which potentially provide better screening results than traditional antibodies. In the field of diagnostics, the company is working on the development of diagnostic test systems for disease diagnosis. Avacta has started developing diagnostic test kits for Covid-19 that can be used in a laboratory or at home. The company also has a partnership with Adeptrix, a diagnostic tool manufacturing company. Another important area of Avacta is therapeutic applications. Avacta's Affimer technology has already led to new clinical approaches in the development of cancer therapies. Avacta also has a pipeline program of Affimer therapeutics targeting various diseases, from cancer to inflammatory and neurodegenerative diseases. Avacta's products include licensed services for pharmaceutical companies, research kits for Affimer technology, and its own portfolio of Affimer products for various applications in research and diagnostics. The products are exported worldwide, and the company has offices in the United States and South Korea. Overall, Avacta Group PLC has become a major player in the biotechnology and diagnostics industry by expanding its Affimer technology to various applications. Partnerships with major pharmaceutical companies and the development of diagnostic test systems for Covid-19 have brought the company into the public eye and contribute to strengthening its position as a leading provider of Affimer technology in the industry. Avacta Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Avacta Group's Debt Structure

Avacta Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Avacta Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Avacta Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Avacta Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Avacta Group stock

What is the debt of Avacta Group this year?

Avacta Group has a debt level of 0 GBP this year.

What was the debt of Avacta Group compared to the previous year?

The debt of Avacta Group has increased by -100% compared to the previous year dropped.

What are the consequences of high debt for investors in Avacta Group?

High debt can pose a risk for investors of Avacta Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Avacta Group?

Low debt means that Avacta Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Avacta Group affect the company?

An increase in debt of Avacta Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Avacta Group affect the company?

A reduction in debt of Avacta Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Avacta Group?

Some factors that can influence the debt of Avacta Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Avacta Group so important for investors?

The debts of Avacta Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Avacta Group take to change the debt?

To change the debt, Avacta Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Avacta Group pay?

Over the past 12 months, Avacta Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avacta Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Avacta Group?

The current dividend yield of Avacta Group is .

When does Avacta Group pay dividends?

Avacta Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avacta Group?

Avacta Group paid dividends every year for the past 0 years.

What is the dividend of Avacta Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avacta Group located?

Avacta Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avacta Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avacta Group from 11/19/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Avacta Group pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Avacta Group in the year 2023?

In the year 2023, Avacta Group distributed 0 GBP as dividends.

In which currency does Avacta Group pay out the dividend?

The dividends of Avacta Group are distributed in GBP.